198 related articles for article (PubMed ID: 7599448)
21. Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D.
van Kesteren RG; Duursma SA; Visser WJ; van der Sluys Veer J; Backer Dirks O
Metab Bone Dis Relat Res; 1982; 4(1):31-7. PubMed ID: 7121252
[TBL] [Abstract][Full Text] [Related]
22. Morphometric and dynamic studies of bone changes in hypothyroidism.
Mosekilde L; Melsen F
Acta Pathol Microbiol Scand A; 1978 Jan; 86(1):56-62. PubMed ID: 636889
[TBL] [Abstract][Full Text] [Related]
23. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
[TBL] [Abstract][Full Text] [Related]
24. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
Søgaard CH; Mosekilde L; Richards A; Mosekilde L
Bone; 1994; 15(4):393-9. PubMed ID: 7917577
[TBL] [Abstract][Full Text] [Related]
25. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
Schnitzler CM; Mesquita JM; Gear KA; Robson HJ; Moodley GP; Smyth AE
J Bone Miner Res; 1990 Feb; 5(2):141-52. PubMed ID: 2316402
[TBL] [Abstract][Full Text] [Related]
26. Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women.
Ott SM; Oleksik A; Lu Y; Harper K; Lips P
J Bone Miner Res; 2002 Feb; 17(2):341-8. PubMed ID: 11811565
[TBL] [Abstract][Full Text] [Related]
27. Bone formation periods studied with triple tetracycline labels in women with postmenopausal osteoporosis.
Ott SM
J Bone Miner Res; 1993 Apr; 8(4):443-50. PubMed ID: 8475794
[TBL] [Abstract][Full Text] [Related]
28. Bone histomorphometry in 22 male patients with normocalciuric idiopathic osteoporosis.
Ciria-Recasens M; Pérez-Edo L; Blanch-Rubió J; Mariñoso ML; Benito-Ruiz P; Serrano S; Carbonell-Abelló J
Bone; 2005 May; 36(5):926-30. PubMed ID: 15794926
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.
Jiang Y; Zhao JJ; Mitlak BH; Wang O; Genant HK; Eriksen EF
J Bone Miner Res; 2003 Nov; 18(11):1932-41. PubMed ID: 14606504
[TBL] [Abstract][Full Text] [Related]
30. Bone structure and turnover in the distal radius and iliac crest: a histomorphometric study.
Schnitzler CM; Biddulph SL; Mesquita JM; Gear KA
J Bone Miner Res; 1996 Nov; 11(11):1761-8. PubMed ID: 8915784
[TBL] [Abstract][Full Text] [Related]
31. Low-intensity pulsed ultrasound increases bone volume, osteoid thickness and mineral apposition rate in the area of fracture healing in patients with a delayed union of the osteotomized fibula.
Rutten S; Nolte PA; Korstjens CM; van Duin MA; Klein-Nulend J
Bone; 2008 Aug; 43(2):348-354. PubMed ID: 18538648
[TBL] [Abstract][Full Text] [Related]
32. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
Chavassieux PM; Arlot ME; Reda C; Wei L; Yates AJ; Meunier PJ
J Clin Invest; 1997 Sep; 100(6):1475-80. PubMed ID: 9294113
[TBL] [Abstract][Full Text] [Related]
33. Trabecular bone mineralization lag time determined by tetracycline double-labeling in normal and certain pathological conditions.
Melsen F; Mosekilde L
Acta Pathol Microbiol Scand A; 1980 Mar; 88(2):83-8. PubMed ID: 7368937
[TBL] [Abstract][Full Text] [Related]
34. Fluoride therapy for osteoporosis: characterization of the skeletal response by serial measurements of serum alkaline phosphatase activity.
Farley SM; Wergedal JE; Smith LC; Lundy MW; Farley JR; Baylink DJ
Metabolism; 1987 Mar; 36(3):211-8. PubMed ID: 3821502
[TBL] [Abstract][Full Text] [Related]
35. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
36. Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis.
Szejnfeld VL; Monier-Faugere MC; Bognar BJ; Ferraz MB; Malluche HH
J Rheumatol; 1997 Apr; 24(4):683-8. PubMed ID: 9101502
[TBL] [Abstract][Full Text] [Related]
37. Morphometric and dynamic studies of bone changes in hyperthyroidism.
Melsen F; Mosekilde L
Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):141-50. PubMed ID: 848285
[TBL] [Abstract][Full Text] [Related]
38. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
[TBL] [Abstract][Full Text] [Related]
39. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
[TBL] [Abstract][Full Text] [Related]
40. [Histomorphometric profile of bone fluorosis induced by prolonged ingestion of Vichy Saint-Yorre water. Comparison with bone fluorine levels].
Boivin G; Chavassieux P; Chapuy MC; Baud CA; Meunier PJ
Pathol Biol (Paris); 1986 Jan; 34(1):33-9. PubMed ID: 3517768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
